1ECW
| CRYSTAL STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS MATRIX ANTIGEN (SIV MA) AT 293K. | 分子名称: | GAG POLYPROTEIN, ISOPROPYL ALCOHOL | 著者 | Rao, Z, Belyaev, A, Fry, E, Roy, P, Jones, I.M, Stuart, D.I. | 登録日 | 2000-01-26 | 公開日 | 2000-02-16 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Crystal structure of SIV matrix antigen and implications for virus assembly. Nature, 378, 1995
|
|
1ED1
| CRYSTAL STRUCTURE OF SIMIAN IMMUNODEFICIENCY VIRUS MATRIX ANTIGEN (SIV MA) AT 100K. | 分子名称: | GAG POLYPROTEIN, ISOPROPYL ALCOHOL | 著者 | Rao, Z, Belyaev, A, Fry, E, Roy, P, Jones, I.M, Stuart, D.I. | 登録日 | 2000-01-26 | 公開日 | 2000-02-16 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (2.1 Å) | 主引用文献 | Crystal structure of SIV matrix antigen and implications for virus assembly. Nature, 378, 1995
|
|
2CDF
| Structure and binding kinetics of three different human CD1d-alpha- Galactosylceramide-specific T cell receptors (TCR 5E) | 分子名称: | TCR 5E | 著者 | Gadola, S.D, Koch, M, Marles-Wright, J, Lissin, N.M, Sheperd, D, Matulis, G, Harlos, K, Villiger, P.M, Stuart, D.I, Jakobsen, B.K, Cerundolo, V, Jones, E.Y. | 登録日 | 2006-01-23 | 公開日 | 2006-03-07 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.25 Å) | 主引用文献 | Structrue and Binding Kinetics of Three Different Human Cd1D-Alpha-Galactosylceramide-Specific T Cell Receptors J.Exp.Med., 203, 2006
|
|
2CME
| The crystal structure of SARS coronavirus ORF-9b protein | 分子名称: | DECANE, HYPOTHETICAL PROTEIN 5 | 著者 | Meier, C, Aricescu, A.R, Assenberg, R, Aplin, R.T, Gilbert, R.J.C, Grimes, J.M, Stuart, D.I. | 登録日 | 2006-05-06 | 公開日 | 2006-07-19 | 最終更新日 | 2024-05-08 | 実験手法 | X-RAY DIFFRACTION (2.8 Å) | 主引用文献 | The Crystal Structure of Orf-9B, a Lipid Binding Protein from the Sars Coronavirus. Structure, 14, 2006
|
|
7Z3Z
| Locked Wuhan SARS-CoV2 Prefusion Spike ectodomain with lipid bound | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, STEARIC ACID, ... | 著者 | Duyvesteyn, H.M.E, Carrique, L, Ren, J, Stuart, D.I, Fry, E.E. | 登録日 | 2022-03-03 | 公開日 | 2022-05-04 | 実験手法 | ELECTRON MICROSCOPY (3.1 Å) | 主引用文献 | The SARS-CoV-2 Spike harbours a lipid binding pocket which modulates stability of the prefusion trimer bioRxiv, 2020
|
|
6YB7
| SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19). | 分子名称: | 3C-like proteinase, DI(HYDROXYETHYL)ETHER, DIMETHYL SULFOXIDE | 著者 | Owen, C.D, Lukacik, P, Strain-Damerell, C.M, Douangamath, A, Powell, A.J, Fearon, D, Brandao-Neto, J, Crawshaw, A.D, Aragao, D, Williams, M, Flaig, R, Hall, D.R, McAuley, K.E, Mazzorana, M, Stuart, D.I, von Delft, F, Walsh, M.A. | 登録日 | 2020-03-16 | 公開日 | 2020-03-25 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (1.25 Å) | 主引用文献 | COVID-19 main protease with unliganded active site To Be Published
|
|
6YM0
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab (crystal form 1) | 分子名称: | Spike glycoprotein, heavy chain, light chain | 著者 | Huo, J, Zhao, Y, Ren, J, Zhou, D, Ginn, H.M, Fry, E.E, Owens, R, Stuart, D.I. | 登録日 | 2020-04-07 | 公開日 | 2020-04-29 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (4.36 Å) | 主引用文献 | Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe, 28, 2020
|
|
6YOR
| Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab | 分子名称: | IgG H chain, IgG L chain, Spike glycoprotein | 著者 | Huo, J, Zhao, Y, Ren, J, Zhou, D, Duyvesteyn, H.M.E, Carrique, L, Malinauskas, T, Ruza, R.R, Shah, P.N.M, Fry, E.E, Owens, R, Stuart, D.I. | 登録日 | 2020-04-15 | 公開日 | 2020-04-29 | 最終更新日 | 2022-04-06 | 実験手法 | ELECTRON MICROSCOPY (3.3 Å) | 主引用文献 | Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe, 28, 2020
|
|
6YLA
| Crystal structure of the SARS-CoV-2 receptor binding domain in complex with CR3022 Fab | 分子名称: | 2-(2-METHOXYETHOXY)ETHANOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, DIMETHYL SULFOXIDE, ... | 著者 | Huo, J, Zhao, Y, Ren, J, Zhou, D, Ginn, H.M, Fry, E.E, Owens, R, Stuart, D.I. | 登録日 | 2020-04-06 | 公開日 | 2020-04-15 | 最終更新日 | 2024-10-23 | 実験手法 | X-RAY DIFFRACTION (2.42 Å) | 主引用文献 | Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe, 28, 2020
|
|
6Z3P
| Structure of EV71 in complex with a protective antibody 38-3-11A Fab | 分子名称: | SPHINGOSINE, VP1, VP2, ... | 著者 | Zhou, D, Fry, E.E, Ren, J, Stuart, D.I. | 登録日 | 2020-05-21 | 公開日 | 2020-09-02 | 最終更新日 | 2024-10-23 | 実験手法 | ELECTRON MICROSCOPY (2.8 Å) | 主引用文献 | Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71. Nat Commun, 11, 2020
|
|
6Y84
| SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19) | 分子名称: | 3C-like proteinase nsp5, DIMETHYL SULFOXIDE | 著者 | Owen, C.D, Lukacik, P, Strain-Damerell, C.M, Douangamath, A, Powell, A.J, Fearon, D, Brandao-Neto, J, Crawshaw, A.D, Aragao, D, Williams, M, Flaig, R, Hall, D.R, McAuley, K.E, Mazzorana, M, Stuart, D.I, von Delft, F, Walsh, M.A. | 登録日 | 2020-03-03 | 公開日 | 2020-03-11 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (1.39 Å) | 主引用文献 | COVID-19 main protease with unliganded active site To Be Published
|
|
6Z3Q
| Structure of EV71 in complex with a protective antibody 38-1-10A Fab | 分子名称: | Heavy chain, Light chain, SPHINGOSINE, ... | 著者 | Zhou, D, Fry, E.E, Ren, J, Stuart, D.I. | 登録日 | 2020-05-21 | 公開日 | 2020-09-02 | 最終更新日 | 2024-10-23 | 実験手法 | ELECTRON MICROSCOPY (2.7 Å) | 主引用文献 | Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71. Nat Commun, 11, 2020
|
|
6Z6W
| Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) from a mammalian expression system. | 分子名称: | Capsid proteins, VP0, VP1, ... | 著者 | Bahar, M.W, Porta, C, Fry, E.E, Stuart, D.I. | 登録日 | 2020-05-29 | 公開日 | 2020-12-30 | 最終更新日 | 2024-07-10 | 実験手法 | ELECTRON MICROSCOPY (3 Å) | 主引用文献 | Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines. NPJ Vaccines, 6, 2021
|
|
8ANW
| Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8). | 分子名称: | Capsid protein, VP0, VP1, ... | 著者 | Bahar, M.W, Fry, E.E, Stuart, D.I. | 登録日 | 2022-08-06 | 公開日 | 2022-10-12 | 最終更新日 | 2024-03-27 | 実験手法 | ELECTRON MICROSCOPY (2.7 Å) | 主引用文献 | Production and Characterisation of Stabilised PV-3 Virus-like Particles Using Pichia pastoris . Viruses, 14, 2022
|
|
8AYY
| Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) in complex with GSH and Pleconaril | 分子名称: | 3-{3,5-DIMETHYL-4-[3-(3-METHYL-ISOXAZOL-5-YL)-PROPOXY]-PHENYL}-5-TRIFLUOROMETHYL-[1,2,4]OXADIAZOLE, Capsid protein, VP0, ... | 著者 | Bahar, M.W, Fry, E.E, Stuart, D.I. | 登録日 | 2022-09-04 | 公開日 | 2022-12-07 | 最終更新日 | 2024-07-24 | 実験手法 | ELECTRON MICROSCOPY (2.6 Å) | 主引用文献 | A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol, 5, 2022
|
|
8AYX
| Poliovirus type 3 (strain Saukett) stabilised virus-like particle (PV3 SC8) in complex with GSH and GPP3 | 分子名称: | 1-[(3S)-5-[4-[(E)-ETHOXYIMINOMETHYL]PHENOXY]-3-METHYL-PENTYL]-3-PYRIDIN-4-YL-IMIDAZOLIDIN-2-ONE, Capsid protein, VP0, ... | 著者 | Bahar, M.W, Fry, E.E, Stuart, D.I. | 登録日 | 2022-09-04 | 公開日 | 2022-12-07 | 最終更新日 | 2024-07-24 | 実験手法 | ELECTRON MICROSCOPY (2.5 Å) | 主引用文献 | A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol, 5, 2022
|
|
8AYZ
| Poliovirus type 2 (strain MEF-1) virus-like particle in complex with capsid binder compound 17 | 分子名称: | 4-[[4-[1,3-bis(oxidanylidene)isoindol-2-yl]phenyl]sulfonylamino]benzoic acid, Capsid protein, VP0, ... | 著者 | Bahar, M.W, Fry, E.E, Stuart, D.I. | 登録日 | 2022-09-04 | 公開日 | 2022-12-07 | 最終更新日 | 2024-07-24 | 実験手法 | ELECTRON MICROSCOPY (1.88 Å) | 主引用文献 | A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation. Commun Biol, 5, 2022
|
|
6ZFO
| Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, EY6A heavy chain, EY6A light chain, ... | 著者 | Duyvesteyn, H.M.E, Zhou, D, Zhao, Y, Fry, E.E, Ren, J, Stuart, D.I. | 登録日 | 2020-06-17 | 公開日 | 2020-07-08 | 最終更新日 | 2021-12-22 | 実験手法 | ELECTRON MICROSCOPY (4.4 Å) | 主引用文献 | Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat.Struct.Mol.Biol., 27, 2020
|
|
6Z3K
| Structure of protective antibody 38-1-10A Fab | 分子名称: | 1,2-ETHANEDIOL, Heavy chain, Light Chain | 著者 | Zhou, D, Fry, E.E, Ren, J, Stuart, D.I. | 登録日 | 2020-05-20 | 公開日 | 2020-09-02 | 最終更新日 | 2024-01-24 | 実験手法 | X-RAY DIFFRACTION (2.7 Å) | 主引用文献 | Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71. Nat Commun, 11, 2020
|
|
6Z97
| Structure of the prefusion SARS-CoV-2 spike glycoprotein | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Spike glycoprotein,Fibritin | 著者 | Duyvesteyn, H.M.E, Ren, J, Zhao, Y, Zhou, D, Huo, J, Carrique, L, Malinauskas, T, Ruza, R.R, Shah, P.N.M, Fry, E.E, Owens, R, Stuart, D.I. | 登録日 | 2020-06-03 | 公開日 | 2020-07-01 | 最終更新日 | 2020-09-23 | 実験手法 | ELECTRON MICROSCOPY (3.4 Å) | 主引用文献 | Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Cell Host Microbe, 28, 2020
|
|
6ZDH
| SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, EY6A heavy chain, ... | 著者 | Duyvesteyn, H.M.E, Zhou, D, Zhao, Y, Fry, E.E, Ren, J, Stuart, D.I. | 登録日 | 2020-06-14 | 公開日 | 2020-07-01 | 最終更新日 | 2024-10-23 | 実験手法 | ELECTRON MICROSCOPY (3.7 Å) | 主引用文献 | Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient. Nat.Struct.Mol.Biol., 27, 2020
|
|
6Z43
| Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanobody, ... | 著者 | Ruza, R.R, Duyvesteyn, H.M.E, Shah, P, Carrique, L, Ren, J, Malinauskas, T, Zhou, D, Stuart, D.I, Naismith, J.H. | 登録日 | 2020-05-22 | 公開日 | 2020-06-03 | 最終更新日 | 2024-10-16 | 実験手法 | ELECTRON MICROSCOPY (3.3 Å) | 主引用文献 | Structural basis for a potent neutralising single-domain antibody that blocks SARS-CoV-2 binding to its receptor ACE2 To Be Published
|
|
1LMW
| LMW U-PA Structure complexed with EGRCMK (GLU-GLY-ARG Chloromethyl Ketone) | 分子名称: | L-alpha-glutamyl-N-{(1S)-4-{[amino(iminio)methyl]amino}-1-[(1S)-2-chloro-1-hydroxyethyl]butyl}glycinamide, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 著者 | Spraggon, G.S, Phillips, C, Nowak, U.K, Ponting, C.P, Saunders, D, Dobson, C.M, Stuart, D.I, Jones, E.Y. | 登録日 | 1995-07-26 | 公開日 | 1996-01-29 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (2.5 Å) | 主引用文献 | The crystal structure of the catalytic domain of human urokinase-type plasminogen activator. Structure, 3, 1995
|
|
1LQB
| Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B complex | 分子名称: | Elongin B, Elongin C, Hypoxia-inducible factor 1 ALPHA, ... | 著者 | Hon, W.C, Wilson, M.I, Harlos, K, Claridge, T.D, Schofield, C.J, Pugh, C.W, Maxwell, P.H, Ratcliffe, P.J, Stuart, D.I, Jones, E.Y. | 登録日 | 2002-05-09 | 公開日 | 2002-07-03 | 最終更新日 | 2023-08-16 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature, 417, 2002
|
|
1LKI
| THE CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTION OF LEUKEMIA INHIBITORY FACTOR: IMPLICATIONS FOR RECEPTOR BINDING | 分子名称: | LEUKEMIA INHIBITORY FACTOR | 著者 | Robinson, R.C, Grey, L.M, Staunton, D, Stuart, D.I, Heath, J.K, Jones, E.Y. | 登録日 | 1994-12-12 | 公開日 | 1995-03-31 | 最終更新日 | 2024-06-05 | 実験手法 | X-RAY DIFFRACTION (2 Å) | 主引用文献 | The crystal structure and biological function of leukemia inhibitory factor: implications for receptor binding. Cell(Cambridge,Mass.), 77, 1994
|
|